WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease. The findings from a phase 3 clinical trial have yet to be peer-reviewed in any medical journal. But according to aContinue Reading

WEDNESDAY, Sept. 28, 2022 (HealthDay News) — It’s very frustrating to get a COVID-19 vaccine and then wind up catching the virus anyway. But these breakthrough infections actually do you a world of good, providing a powerful boost to your existing vaccine-induced immune protection, a new study reports. People infectedContinue Reading

WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Combining weightlifting with aerobic exercise can significantly lower your odds dying early, especially from heart disease, new research shows. Depending how much weightlifting they did, older adults reduced their risk of premature death by between 9% and 22%, the study found. Moderate orContinue Reading

WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on immune-suppressing drugs to prevent organ rejection developed a mutated version of SARS-CoV-2 resistantContinue Reading